Hikal Ltd.

280.20 +0.05 ▲0.0%

29 February 2024, 04:01:00 PM
Volume: 8,636

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hikal.com
Market Cap 3,454.89 Cr.
Enterprise Value(EV) 4,191.60 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 5.81 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 47.91 Trailing Twelve Months Ending 2023-12
Industry PE 41.39 Trailing Twelve Months Ending 2023-12
Book Value / Share 94.19 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.97 Calculated using Price: 280.20
Dividend Yield 0.43 Period Ending 2023-03
No. of Shares Subscribed 12.33 Cr. 123,300,750 Shares
FaceValue 2
About Hikal Ltd.
Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA.

Hikal Ltd. Delivery

Delivered Qty
Traded Qty

Hikal Ltd. Performance

1 Day
+0.02%
1 Week
-1.82%
1 Month
-0.48%
3 Month
+2.96%
6 Month
-1.79%
1 Year
-4.89%
2 Year
-23.58%
5 Year
+73.71%
10 Year
+349.11%

Hikal Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 9.81 9.32 12.74 12.12 14.46 10.74 15.22 16.04 7.12
Return on Capital Employed (%) 12.5 11.92 11.87 12.81 15.25 12.44 16.15 15.21 8.47
Return on Assets (%) 3.12 3.17 5.02 5.15 6.11 4.62 6.84 7.39 3.27

Hikal Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 532 564 605 669 756 817 933 1,068 1,133 1,145
Non Curr. Liab. 242 337 324 312 359 410 379 432 646 546
Curr. Liab. 530 397 470 616 659 653 703 828 691 699
Minority Int.
Equity & Liab. 1,304 1,298 1,400 1,597 1,775 1,879 2,016 2,328 2,471 2,391
Non Curr. Assets 791 808 793 851 888 1,048 1,091 1,305 1,502 1,497
Curr. Assets 513 490 607 746 886 831 925 1,023 968 894
Misc. Exp. not W/O
Total Assets 1,304 1,298 1,400 1,597 1,775 1,879 2,016 2,328 2,471 2,391

Hikal Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 872 926 1,014 1,296 1,590 1,507 1,720 1,943 2,023 1,816
Other Income 2 2 3 4 2 4 5 5 5 2
Total Income 873 927 1,017 1,301 1,592 1,511 1,725 1,948 2,028 1,818
Total Expenditure -689 -745 -815 -1,054 -1,291 -1,234 -1,398 -1,602 -1,766 -1,555
PBIDT 184 183 202 246 300 277 328 345 262 263
Interest -60 -62 -48 -49 -58 -52 -36 -31 -48 -54
Depreciation -64 -67 -69 -86 -93 -82 -85 -96 -109 -112
Taxation -19 -12 -13 -34 -46 -42 -73 -58 -27 -25
Exceptional Items -4 -15
PAT 40 41 68 77 103 84 133 161 78 72
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 40 41 68 77 103 84 133 161 78 72
Adjusted EPS 3 3 5 6 8 7 11 13 6 6

Hikal Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 154 102 186 163 139 186 285 229 294 315
Cash Fr. Inv. -23 -43 -64 -102 -110 -125 -164 -156 -284 -292
Cash Fr. Finan. -124 -69 -124 -63 -25 -55 -101 -97 -6 -8
Net Change 7 -10 -2 -2 4 6 20 -24 4 15
Cash & Cash Eqvt 16 6 4 2 6 11 32 8 11 27

Hikal Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 68.77 68.77 68.77 68.77 68.83 68.85 68.85 68.85 68.85
Public 31.23 31.23 31.23 31.23 31.17 31.15 31.15 31.15 31.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Hikal Ltd. Announcements

Fri, 23 Feb 2024
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015
Announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Tue, 20 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Newspaper Publication
Mon, 19 Feb 2024
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot pursuant to the provision of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Hikal Ltd. Technical Scans

Wed, 28 Feb 2024
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Hikal Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 377,475.37 1,577.95 +0.3%
Cipla Ltd. 119,187.32 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,206.64 6,424.25 -0.1%
Zydus Lifesciences Ltd. 94,418.40 941.90 +1.0%
Divi's Laboratories Ltd. 93,236.55 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. 91,390.97 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. 88,302.11 2,666.80 +2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.38 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.14 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.51 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.75 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 67.42 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.78 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,666.80 +2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.05 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.60 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.86 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.15 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.53 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,666.80 +2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%

Hikal Ltd. FAQ's

What is Hikal share price?

Can I buy Hikal shares now?

What is the Dividend Yield of Hikal?

What is the Market Cap of Hikal?

What are the key metrics to analyse Hikal?

What is the 52 Week High and Low of Hikal?

What is the trend of Hikal share price?